Search - tctmd.com

Displaying 461 - 480 of 1649

Sort: Relevancy | Date

ChatGPT et al? Not So Fast, Say Journal Editors

News Features

ChatGPT et al? Not So Fast, Say Journal Editors

Yael L. Maxwell

April 05, 2023

The Promise of AI for Improving Health Equity in Heart Failure

News Features THT 2023

The Promise of AI for Improving Health Equity in Heart Failure

April 04, 2023

Severe Infections Linked to a Variety of CV Events, Both Acute and Long-term

News Daily News

Severe Infections Linked to a Variety of CV Events, Both Acute and Long-term

March 28, 2023

MI Risk in Subclinical CAD? Both Extent and Stenosis Severity Matter

News Daily News

MI Risk in Subclinical CAD? Both Extent and Stenosis Severity Matter

Yael L. Maxwell

March 27, 2023

Preliminary Results Suggest Benefit of Splanchnic Nerve Ablation in HFpEF

News Conference News THT 2023

Preliminary Results Suggest Benefit of Splanchnic Nerve Ablation in HFpEF

March 22, 2023

TEER or VAD/Transplant in the Advanced HF Patient With MR?

News Conference News THT 2023

TEER or VAD/Transplant in the Advanced HF Patient With MR?

March 20, 2023

Pregnancy Health, Mortality Link Especially Pronounced in Black Women

News Daily News

Pregnancy Health, Mortality Link Especially Pronounced in Black Women

Yael L. Maxwell

March 17, 2023

Acute AF Can Recur: Manage and Monitor Long-term, Says AHA

News Daily News

Acute AF Can Recur: Manage and Monitor Long-term, Says AHA

Michael O'Riordan

March 16, 2023

Mediterranean Diet’s CV Benefits Extend to Women: Meta-analysis

News Daily News

Mediterranean Diet’s CV Benefits Extend to Women: Meta-analysis

March 15, 2023

IMPLEMENT-HF: ‘Virtual’ Stewardship May Help Optimize GDMT in HFrEF

News Conference News ACC 2023

IMPLEMENT-HF: ‘Virtual’ Stewardship May Help Optimize GDMT in HFrEF

March 14, 2023

Oral PCSK9 Inhibitor Reduces LDL Cholesterol in Phase IIb Study

News Conference News ACC 2023

Oral PCSK9 Inhibitor Reduces LDL Cholesterol in Phase IIb Study

March 10, 2023

‘Causal AI’ May Help Guide Specific Actions to Reduce CVD Risk

News Conference News ACC 2023

‘Causal AI’ May Help Guide Specific Actions to Reduce CVD Risk

March 10, 2023

HALO: Baxdrostat No Better Than Placebo in Uncontrolled Hypertension

News Conference News ACC 2023

HALO: Baxdrostat No Better Than Placebo in Uncontrolled Hypertension

March 08, 2023

Free Meds Don’t Reduce CV Events, but Tailored Messaging Does: ACCESS

News Conference News ACC 2023

Free Meds Don’t Reduce CV Events, but Tailored Messaging Does: ACCESS

March 05, 2023

RAPID-HF: Rate-Adaptive Pacing Doesn’t Help in HFpEF

News Conference News ACC 2023

RAPID-HF: Rate-Adaptive Pacing Doesn’t Help in HFpEF

March 05, 2023

Self-Expanding TAVI Holds Up to Surgery Out to 3 Years in Low-Risk Patients

News Conference News ACC 2023

Self-Expanding TAVI Holds Up to Surgery Out to 3 Years in Low-Risk Patients

March 05, 2023

TRILUMINATE Pivotal: TEER With the TriClip Benefits Patients With Severe TR

News Conference News ACC 2023

TRILUMINATE Pivotal: TEER With the TriClip Benefits Patients With Severe TR

March 04, 2023

Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes

News Conference News ACC 2023

Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes

Michael O'Riordan

March 04, 2023

Worse CABG Outcomes in Women Haven’t Budged in Over a Decade: STS

News Daily News

Worse CABG Outcomes in Women Haven’t Budged in Over a Decade: STS

March 03, 2023

Life’s Essential 8 Linked to More Years Free of Chronic Disease

News Daily News

Life’s Essential 8 Linked to More Years Free of Chronic Disease

February 28, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.